Advertisement

BIMI Holdings Inc. BIMI

Set alert

Price alert · BIMI

All alert types
0.00 USD 0.00 0.00%

At close · Oct 29

0.0001 Day range 0.0001
0.0001 52-week range 0.0005
YTD
0.00%
1 year
0.00%
Open
0.0001
Prev close
0.0001
Mkt cap
1.40K
Vol
26.25K
Avg vol
472
EPS
-1.03
P/E
0.00
Div yield
0.00%
More statistics
Low
0.0001
High
0.0001
Forward P/E
0.00
Beta
1.74
Short ratio
0.27
Inst. own
0.49%
Dividend
0.00
Ex-div date
50-d avg
0.4896
200-d avg
1.62
1y target
0.00

2Y chart

Chart tools
Interval

Signals (35)
NameDateAgo
SMA: BearishOct 28, 20263 days ago
SMA: BearishOct 28, 20263 days ago
SMA: BullishOct 16, 20262 weeks ago
SMA: BullishOct 16, 20262 weeks ago
SMA: BearishOct 15, 20262 weeks ago
SMA: BearishOct 15, 20262 weeks ago
MACD: Sell SignalOct 15, 20262 weeks ago
MACD: Buy SignalOct 7, 20263 weeks ago
SMA: BullishOct 6, 20263 weeks ago
SMA: BullishOct 6, 20263 weeks ago
SMA: BearishOct 2, 20264 weeks ago
SMA: BearishOct 2, 20264 weeks ago
RSI: OversoldOct 2, 20264 weeks ago
MACD: Sell SignalSep 22, 20261 month ago
RSI: OverboughtSep 8, 20261 month ago
MACD: Buy SignalAug 26, 20251 year ago
MACD: Sell SignalJul 28, 20251 year ago
SMA: BearishJul 23, 20251 year ago
SMA: BullishJul 21, 20251 year ago
RSI: OverboughtJul 21, 20251 year ago
MACD: Buy SignalJun 9, 20251 year ago
MACD: Sell SignalMay 14, 20251 year ago
SMA: BearishMay 13, 20251 year ago
SMA: BullishMay 12, 20251 year ago
MACD: Buy SignalMay 12, 20251 year ago
SMA: BearishMay 9, 20251 year ago
MACD: Sell SignalMay 8, 20251 year ago
MACD: Buy SignalMay 7, 20251 year ago
MACD: Sell SignalApr 30, 20251 year ago
RSI: OverboughtApr 23, 20251 year ago
SMA: BullishMar 18, 20251 year ago
RSI: OversoldMar 7, 20251 year ago
MACD: Buy SignalJan 14, 20251 year ago
MACD: Sell SignalDec 24, 20241 year ago
RSI: OversoldDec 20, 20241 year ago

Key statistics

Market cap
418.82K
Enterprise value
5.78M
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.03
Price / book
0.02
EPS (TTM)
-6.39
Beta
1.74
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-83.20%
Revenue (TTM)
12.63M
Revenue growth
-48.80%
Free cash flow
-5.75M
Total cash
994.13K
Total debt
4.99M
Return on equity
-103.78%
Shares outstanding
13.96M
Short % of float
2.57%
50-day average
0.4896
200-day average
1.62

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
BIMI Revenue — quarterly 2.52M
2019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 2023
BIMI Net income — quarterly -3.13M
2019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 2023
BIMI EPS — quarterly -0.51
2019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 2023

Earnings

BIMI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Dec 19, 2023Sep 1, 20230.00-0.49——
Nov 22, 2023Jun 1, 20230.000.26——
May 19, 2023Mar 1, 20230.00-0.24——
Nov 21, 2022Sep 1, 20220.00-1.60——
Aug 22, 2022Jun 1, 20220.00-1.80——
May 20, 2022Mar 1, 20220.00-2.70——

About BIMI Holdings Inc.

BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes varieties of products, including raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services; and operates two private hospitals in China. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. BIMI Holdings Inc. was incorporated in 2000 and is headquartered in New York, New York.

Sector
Healthcare
Industry
Pharmaceutical Retailers
Country
United States
Website
usbimi.com

News

Your note

Sign in to keep a note on BIMI — it syncs with the Stock Master app.

Insider holders

BIMI insider holders
InsiderRelationLatest transactionDateShares held
GANG LIChief Executive OfficerSaleApr 8, 20180
LIAONING NENGFA WEIYE NEW ENERGY APPLICATION CO LTDBeneficial Owner of more than 10% of a Class of SecuritySaleJun 16, 20090
LIHUA WANGChief Financial OfficerSaleApr 8, 20180
OUDOM FNUDirector and Beneficial Owner of more than 10% of a Class of SecurityStock Award(Grant)Jun 11, 20241,518,240
SONG TIEWEIChief Executive OfficerSaleFeb 27, 2024337,117

Institution ownership

BIMI institution ownership
Holder% heldSharesValueReported
Natixis0.08%3,4004.76KJun 29, 2023
UBS Group AG0.06%2,4843.48KJun 29, 2023

Fund ownership

BIMI fund ownership
Holder% heldSharesValueReported
Fidelity NASDAQ Composite Index Fund0.01%357353May 30, 2023
Advertisement